Medical and Pharmaceutical New drug could open personalized treatment strategies for prostate cancer Screening men for BCL2 could allow for the development of personalized treatment plans Joseph MortonSeptember 17, 2024
Retail The Children’s Place rebounds with strong second quarter profit Gross profit rose by USD$24.0 million to USD$111.8 million for the three months ending August 3, 2024 Joseph MortonSeptember 17, 2024
Cannabis Northern Canada gets a new cannabis distribution warehouse This C$300,000 marijuana repository in the Northwest Territories will be situated in Hay River Rowan DunneSeptember 16, 2024
Alternative Energy Paladin Energy acquisition of Fission Uranium blocked by Chinese shareholder CGN Mining—a subsidiary of China General Nuclear Power—is opposing the merger Joseph MortonSeptember 16, 2024
Silver Sun Silver intercepts 521 g/t silver equivalent at Maverick Springs This rich 1.5 metre interval was part of an 88-metre core containing 79.6 g/t AgEq Rowan DunneSeptember 16, 2024
Alternative Energy Complete Solar Holdings shares climb 38% after SunPower Corporation acquisition The solar industry's overall boost is driven by increased global focus on renewable energy and U.S. solar manufacturing Joseph MortonSeptember 16, 2024
Medical and Pharmaceutical Prelude Therapeutics Incorporated shares drop 30% on clinical trial news The drug in question is also presently being tested in an ongoing dose-escalation Phase 1 trial for patients with solid tumours Joseph MortonSeptember 13, 2024
Gold B2Gold and Government of Mali come to terms on Fekola mining complex Mining operations will begin once the exploitation permit for Fekola Regional is granted Joseph MortonSeptember 13, 2024
Bitcoin India goes after big name crypto exchanges for backtaxes and regulatory noncompliance The Financial Intelligence Unit issued compliance show cause notices to nine prominent exchanges Joseph MortonSeptember 12, 2024
Technology Netgear stock soars on settlement news and stronger Q3 outlook Initially set at USD$160-175 million, the revised revenue forecast now stands at USD$170-180 million Joseph MortonSeptember 12, 2024